EC News Analysis

Kai Kloepfer started biometric “smart” gun startup Biofire as a science fair project after the Aurora, Colorado, mass shooting in 2012 brought the U.S.’s gun violence problem close to home.…

Deal Dive: VCs are no longer gunshy about firearm startups

VCs have long supported fast-fashion companies but the controversies and lawsuits they draw makes them riskier investments.

Deal Dive: It’s time for VCs to break up with fast fashion

Pitch competitions are a bright spot for underrepresented founders but not without burdens that regular funding doesn’t have.

Pitch competitions help level the playing field for underrepresented founders, but it isn’t enough

Reddit’s feeling out its own IPO valuation is crucial, especially given that hightened regulatory scrutiny is restricting M&A as an exit avenue for unicorns.

Reddit at $5B seems eminently reasonable

Boomerang thinks so. It uses machine learning to match photos and descriptions of lost items to streamline the lost and found process.

Deal Dive: Can AI fix lost and found?

If you’re thinking about raising a Series A, you should probably start now.

Here’s what to know to raise a Series A right now

Let’s make one thing clear: Reddit going public in the first quarter is not going to throw the IPO window wide open for other private tech companies.

Counting down to the Reddit IPO (again)

Most VCs think valuations are close to the bottom, if not already there, but few think there will be any relief in 2024.

Will startup valuations start to recover in 2024? Investors aren’t so sure

As long as micro funds can be nimble enough to gain meaningful ownership, they shouldn’t be too concerned about Countdown’s fate.

Countdown Capital winding down is not a bad omen for micro funds

Featured Article

Deal Dive: Tier and Dott’s merger is not a sign of what’s to come in M&A this year

M&A is expected to rise in 2024, but we won’t likely see a lot of consolidation among startups that wouldn’t make it on their own.

Deal Dive: Tier and Dott’s merger is not a sign of what’s to come in M&A this year

More than 100 companies are getting ready to go public on Nasdaq after filing confidentially with the SEC, Barron’s quoted Nasdaq’s CEO Adena Friedman as saying.

Nasdaq CEO’s comments about IPOs portend sunny skies ahead for the tech industry
Startups

What happens to Carta now?

If a noticeable chunk of Carta startup and venture customers do leave, it would hurt the company’s otherwise impressive revenue figures, but that seems unlikely to happen.

What happens to Carta now?

Is Carta a bad business without a secondary-market trading arm? Can it scale on its other revenue sources to the size it needs to take its large private-market valuation live?

Carta’s growth story is being overshadowed by its stock trading snafu

When we consider Lawson’s tenure, the bulk of the company’s life so far is far more telling of the real story than the past few quarters.

Jeff Lawson’s legacy at Twilio is about more than a few rough quarters

The whole point of a startup is to build something enduring.

The goal of a startup is to cease existing

Some investors are more optimistic about M&A in 2024, while others think we will see a rebound in the IPO market.

VCs anticipate more exits in 2024 but have no consensus on when or how

VCs like to tout they bring value beyond their capital, but many startups say they’ve found the same benefits from crowdfunding investors.

Debunking the myth that crowdfunding is only good for cash

Not much happened when it comes to legal cannabis markets in 2023, which won’t help cannabis startups that are already facing a challenging funding environment.

With hopes for greener grass in Germany vanishing, consolidation is in the cards for cannabis companies

Featured Article

Startups aren’t doing as badly as you might think

A deep dive into the data from startup accounting firm Kruze Consulting shows that startups that can keep an eye on the fundamentals are in pretty decent shape.

Startups aren’t doing as badly as you might think

While valuations have fallen quite a bit, some sectors are still too inflated for secondaries investors to find attractive.

Secondaries investors say some valuations are still too high

Most startup exits look nothing like the Adobe-Figma deal, which means this breakup won’t impact most future startup acquisitions.

The Adobe-Figma breakup isn’t a signal of what’s to come for startup M&A

A critical cohort of tech firms has regained the value it lost after the summer rally, setting the stage for a stronger IPO cycle in early 2024.

The cloud stock rally could help inch open the IPO window in 2024

Besides making allegations of abusing legal systems and agressive contracts, Temu’s lawsuit makes Shein’s business practices look like they’re from a mobster movie.

Temu’s latest lawsuit against Shein is wild

Will Snap’s recent good fortunes benefit X? With new numbers on hand, let’s take a look at X’s financials and its valuation.

What X needs most now is for Snap to post a solid Q4

Google’s losing the antitrust lawsuit concerning the Play Store brought by Epic Games is going to have far-reaching implications for the mobile app economy.

The regulation is coming from inside the house!

Nth Cycle is one of the few startups tackling the cleantech’s carbon-heavy supply chain and building a cleaner infrastructure for the sector.

Deal Dive: Making the clean energy transition, well, cleaner

Secondary activity is expected to return to normal in 2024. Five investors tells us where they are interested and where they are not.

5 secondaries investors tell us what’s hot and what’s not heading into 2024

Secondary activity was inconsistent this year, but if the IPO window opens back up in 2024, secondaries should return with it.

Summer’s secondary surge didn’t last, but 2024 should be strong

Spotify is simply tinkering with its economics so that it is more attractive to investors. That means it needs to pay fewer salaries.

Spotify’s layoffs make sense when you consider its margins and market

RepeatMD recently raised a $50 million Series A round to serve the exploding med spa industry that is built on consumer beauty trends.

Deal Dive: Betting on beauty fads is big business